Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

HHS Medicaid savings agenda must prevail despite opposition

Health and Human Services (HHS) Secretary Kathleen Sebelius should continue encouraging state Medicaid programs to explore more affordable pharmacy solutions despite opposition from the independent drugstore lobby, the Pharmaceutical Care Management Association (PCMA) said today.

9 Feb 2011

Updating approach to pharmacy benefits will help Florida Medicaid save $462 million

"Governor Scott is taking important steps to reduce wasteful spending in Medicaid, which is a big problem when it comes to pharmacy benefits. Because of its old-school 'fee-for-service' approach, Florida Medicaid pays drugstores much more than either Medicare or the commercial market pays them. Over the next decade, Florida could save $462 million - without cutting benefits, eligibility or payments to doctor and hospitals - simply by updating its approach to pharmacy benefits."

9 Feb 2011

UMMC researchers develop MOPAT tool to assess acute pain in non-communicative patients

A valid and reliable tool to assess acute pain in non-communicative patients has been developed by researchers at the University of Maryland School of Nursing.

9 Feb 2011

Pharmacist-directed anticoagulation service improves quality of care for HIT patients

A Henry Ford Hospital study has found that a pharmacist-directed anticoagulation service improves the way medication is managed for patients with heparin-induced thrombocytopenia, a common but life-threatening thromboembolic disorder.

9 Feb 2011

Humana fourth quarter diluted EPS decreases to $0.63

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended December 31, 2010 (4Q10) of $0.63, compared to $1.48 per share for the quarter ended December 31, 2009 (4Q09).

7 Feb 2011

Patient need to share medication side effects with health care team: Retired family doctor

"I had a wonderful gentleman patient who had resistant blood pressure," recalls Vicki Koenig, M.D., a retired family doctor in Exmore, VA. "When he came for a blood pressure check on the latest new med and it was great, I was ecstatic. Then he said, 'But I notice my urine's a little dark.' His was one of the first cases of fatal liver complications from this medication."

5 Feb 2011

Ameritox makes significant strides to advance its industry leadership position

Ameritox, the nation's leader in pain medication monitoring, made significant strides to advance its industry leadership position by strengthening the company's commitment to physicians and patients in the past twelve months.

5 Feb 2011

Scientists awarded grant to study microbiology of Cystic Fibrosis pulmonary infection

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a -1.74 million US-Ireland Research and Development Partnership grant.

4 Feb 2011

Queen's awarded £1.74 million grant to study microbiology of Cystic Fibrosis pulmonary infection

Scientists at Queen's University Belfast have begun work into improving the lives of thousands of Cystic Fibrosis sufferers thanks to the award of a £1.74 million US-Ireland Research and Development Partnership grant.

4 Feb 2011

HHS encourages lower-cost drug usage to help reduce Medicaid spending

With Medicaid spending growth almost doubling over the past year, a new document released today by Health and Human Services Secretary Kathleen Sebelius to all 50 governors encourages the use of lower-cost drugs - including generics - to help reduce Medicaid spending.

4 Feb 2011

CIGNA fourth quarter shareholders' net income increases to $461 million

CIGNA Corporation today reported shareholders' net income of $461 million, or $1.69 per share, for the fourth quarter of 2010 compared with shareholders' net income of $330 million, or $1.19 per share, for the fourth quarter of 2009.

3 Feb 2011

PEARS project reviews professional pharmacy education in Ireland

A research team from Aston University in Birmingham, UK has completed The Pharmacy Education and Accreditation Reviews Project (PEARS), which reviewed professional pharmacy education as a whole in Ireland. The Project was led by Professor Keith Wilson and Dr Chris Langley, who are based in the School of Life & Health Sciences at Aston.

3 Feb 2011

HealthCore, AstraZeneca collaborate to conduct real-world studies on disease states, treatment

AstraZeneca Pharmaceuticals LP and HealthCore, the health outcomes research subsidiary of WellPoint, today announced a collaborative agreement to conduct real-world studies designed to determine how to most effectively and economically treat disease.

3 Feb 2011

New research: Antioxidants in pecans may prevent development of various diseases

A new research study from Loma Linda University demonstrates that naturally occurring antioxidants in pecans may help contribute to heart health and disease prevention; the results are published in the January 2011 issue of The Journal of Nutrition.

2 Feb 2011

CorVel third quarter earnings per share increases 4% to $0.56

CorVel Corporation today announced earnings per share of $0.56 for the quarter ended December 31, 2010, a 4% increase compared to $0.54 in the same quarter of the prior fiscal year. Earnings per share for the nine months ended December 31, 2010 were $1.82, a 20% increase over the $1.52 earnings per share for the nine months ended December 31, 2009.

1 Feb 2011

McLeod Health joins SafetyConnect to effectively monitor clinical data and reduce infections

By eliminating piles of paper, McLeod Health is now able to more effectively monitor clinical data and reduce infections with the help of the Premier healthcare alliance's SafetyConnect™ program.

1 Feb 2011

PCMA finds Ohio's Medicaid program can save $135 million over the next decade

Ohio's Medicaid program could cost taxpayers an additional $1.6 billion next year, a 49 percent jump in the state's share of costs for the health care program covering more than 2 million poor and disabled Ohioans, according to new information released by the Governor's Office of Health Transformation.

1 Feb 2011

Easier access to emergency birth control increases sexually-transmitted diseases among teenagers

Offering the morning after pill free over the counter has not reduced the number of teenage pregnancies and may be associated with a rise in sexually-transmitted diseases (STIs), according to a report by experts at The University of Nottingham.

1 Feb 2011

DNA Direct implements four new health plan clients for molecular diagnostic and genetic tests

DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. and a provider of guidance and decision support for genomic medicine, today announced four new health plan clients that are implementing DNA Direct's Policy & Benefit Support Program for molecular diagnostic and genetic tests.

1 Feb 2011

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

Pharmacy News and Research

Further Reading

HHS Medicaid savings agenda must prevail despite opposition

Updating approach to pharmacy benefits will help Florida Medicaid save $462 million

UMMC researchers develop MOPAT tool to assess acute pain in non-communicative patients

Pharmacist-directed anticoagulation service improves quality of care for HIT patients

Humana fourth quarter diluted EPS decreases to $0.63

Patient need to share medication side effects with health care team: Retired family doctor

Ameritox makes significant strides to advance its industry leadership position

Scientists awarded grant to study microbiology of Cystic Fibrosis pulmonary infection

Queen's awarded £1.74 million grant to study microbiology of Cystic Fibrosis pulmonary infection

HHS encourages lower-cost drug usage to help reduce Medicaid spending

CIGNA fourth quarter shareholders' net income increases to $461 million

PEARS project reviews professional pharmacy education in Ireland

HealthCore, AstraZeneca collaborate to conduct real-world studies on disease states, treatment

New research: Antioxidants in pecans may prevent development of various diseases

CorVel third quarter earnings per share increases 4% to $0.56

McLeod Health joins SafetyConnect to effectively monitor clinical data and reduce infections

PCMA finds Ohio's Medicaid program can save $135 million over the next decade

Easier access to emergency birth control increases sexually-transmitted diseases among teenagers

DNA Direct implements four new health plan clients for molecular diagnostic and genetic tests

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

Pittcon Highlights: Pharmaceutical & Biologic eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News